If a generic is substituted for a brand, how must the patient be notified?

When a generic medication is substituted for a brand-name drug, the law requires that the patient is notified both orally and in writing. This dual notification is important for several reasons.

First, providing oral notification ensures that the patient receives immediate information during the pharmacy visit, allowing for any questions or concerns to be addressed on the spot. Patients may seek clarification about the substitution, potential differences in efficacy, or side effects.

Second, written notification serves as a formal record that the patient has been informed about the substitution. This can be particularly important for patient safety, as it allows patients to understand their treatment and what factors may influence their care. The written information can include details such as the name of the substituted medication, any pertinent information about differences between the generic and brand versions, and reassurance about the efficacy and safety of the generic.

The combination of both oral and written notifications not only fulfills legal requirements but also supports patient empowerment and informed decision-making regarding their medications. This practice helps to ensure that patients are fully aware of their treatment options and can engage appropriately with their healthcare providers.